Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad?

Von Willebrand factor (vWf) is a fundamental multimeric plasma glycoprotein in the coagulation process. Its function is to mediate platelet adhesion and to stabilize circulating factor VIII. A functional or quantitative alteration of vWf gives rise to von Willebrand disease (vWD). The association be...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Salinas Laval,José, Triantafilo,Nicolás, Zúñiga,Pamela
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2020
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020001001475
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872020001001475
record_format dspace
spelling oai:scielo:S0034-988720200010014752021-02-02Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad?Salinas Laval,JoséTriantafilo,NicolásZúñiga,Pamela Angiodysplasia Gastrointestinal Hemorrhage von Willebrand Diseases Von Willebrand factor (vWf) is a fundamental multimeric plasma glycoprotein in the coagulation process. Its function is to mediate platelet adhesion and to stabilize circulating factor VIII. A functional or quantitative alteration of vWf gives rise to von Willebrand disease (vWD). The association between vWD and angiodysplasia was described in 1967, but it was only until 2011 that Starke et al demonstrated the in vitro and in vivo role of vWf in angiogenesis. Congenital or acquired vWf deficiency, especially of high molecular weight multimeters, not only favors bleeding, but also contributes to increased angiogenesis in these patients. The treatment should be focused both on the control of the acute episode of gastrointestinal bleeding, with vWf replacement therapy and local endoscopic treatment, as well as on the prevention of the progression of angiodysplasia and future bleeding. There are different published therapeutic approaches using vWf replacement that are not effective in all patients. Recently, angiogenesis inhibitor medications have been used.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.148 n.10 20202020-10-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020001001475es10.4067/S0034-98872020001001475
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Angiodysplasia
Gastrointestinal Hemorrhage
von Willebrand Diseases
spellingShingle Angiodysplasia
Gastrointestinal Hemorrhage
von Willebrand Diseases
Salinas Laval,José
Triantafilo,Nicolás
Zúñiga,Pamela
Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad?
description Von Willebrand factor (vWf) is a fundamental multimeric plasma glycoprotein in the coagulation process. Its function is to mediate platelet adhesion and to stabilize circulating factor VIII. A functional or quantitative alteration of vWf gives rise to von Willebrand disease (vWD). The association between vWD and angiodysplasia was described in 1967, but it was only until 2011 that Starke et al demonstrated the in vitro and in vivo role of vWf in angiogenesis. Congenital or acquired vWf deficiency, especially of high molecular weight multimeters, not only favors bleeding, but also contributes to increased angiogenesis in these patients. The treatment should be focused both on the control of the acute episode of gastrointestinal bleeding, with vWf replacement therapy and local endoscopic treatment, as well as on the prevention of the progression of angiodysplasia and future bleeding. There are different published therapeutic approaches using vWf replacement that are not effective in all patients. Recently, angiogenesis inhibitor medications have been used.
author Salinas Laval,José
Triantafilo,Nicolás
Zúñiga,Pamela
author_facet Salinas Laval,José
Triantafilo,Nicolás
Zúñiga,Pamela
author_sort Salinas Laval,José
title Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad?
title_short Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad?
title_full Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad?
title_fullStr Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad?
title_full_unstemmed Asociación entre enfermedad de von Willebrand y angiodisplasia: ¿casualidad o causalidad?
title_sort asociación entre enfermedad de von willebrand y angiodisplasia: ¿casualidad o causalidad?
publisher Sociedad Médica de Santiago
publishDate 2020
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020001001475
work_keys_str_mv AT salinaslavaljose asociacionentreenfermedaddevonwillebrandyangiodisplasiacasualidadocausalidad
AT triantafilonicolas asociacionentreenfermedaddevonwillebrandyangiodisplasiacasualidadocausalidad
AT zunigapamela asociacionentreenfermedaddevonwillebrandyangiodisplasiacasualidadocausalidad
_version_ 1718437157838782464